Welcome to our dedicated page for Gohealth SEC filings (Ticker: GOCO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking how GoHealth (GOCO) navigates changing Medicare rules means wading through hundreds of pages of SEC disclosures. Finding policy-persistency metrics in a 10-K or spotting when executives unload shares via Form 4 can feel impossible.
Stock Titan鈥檚 AI solves that problem in seconds. Our platform streams every filing to your dashboard the instant it hits EDGAR, then delivers plain-English summaries that translate actuarial jargon and CMS references into clear business drivers. Whether you need GoHealth insider trading Form 4 transactions, a quick read-through of the GoHealth annual report 10-K simplified, or an alert on the latest GoHealth 8-K material events explained, everything is here鈥攁lready tagged, indexed, and searchable.
Investors typically dig into three core areas:
- Customer economics: Our AI highlights acquisition cost trends buried deep in the quarterly earnings report 10-Q filing.
- Regulatory risk: Material event 8-Ks flag CMS policy shifts practically in real time, so you can act before the market digests them.
- Management signals: Follow GoHealth executive stock transactions Form 4 and board-level compensation details in the proxy statement without combing through appendices.
Stop scrolling endless PDFs. Stock Titan provides comprehensive coverage鈥擣orm S-8s, 424Bs, even the niche N-CSR鈥攑lus AI-powered cross-links that answer natural-language questions like 鈥渦nderstanding GoHealth SEC documents with AI鈥� or 鈥淕oHealth earnings report filing analysis.鈥� Make informed decisions faster with expert context and real-time data.
Kotte Vijay, identified as a director and Chief Executive Officer of GoHealth, Inc. (GOCO), was granted 218,551 restricted stock units on 08/07/2025 under a First Amendment to his employment agreement. The restricted stock units vest in three annual installments, with the first installment vesting on 08/07/2026. Following the reported transaction, the filing shows beneficial ownership of 1,347,396 shares of Class A common stock, which includes 1,798 shares purchased under the company芒鈧劉s Employee Stock Purchase Plan on 06/30/2025. The filing also corrects prior disclosures by reducing previously reported holdings by 94,444 shares that were subject to unmet performance conditions.
On 6 Aug 2025, GoHealth (GOCO) executed a series of financing and governance actions aimed at improving near-term liquidity and extending maturities.
- $115 m super-priority term loan: $80 m in new money ($40 m funded now; $40 m delayed-draw before Dec-25) plus $35 m roll-up of existing revolver. Rate: Term SOFR + 5.50 % (3 % floor) or ABR + 4.50 % (4 % floor) plus a cash MOIC premium of up to 2.0脳. Maturity: 5 Aug 2029. First-lien on substantially all assets and senior to the existing credit facility.
- Covenants: Weekly minimum liquidity starts at $5 m (Oct-25) and rises to $30 m (Sep-26). Borrower barred from prepaying legacy Class A loans until super-priority debt is fully repaid.
- Amendment No. 14: Terminates unused revolver commitments, extends remaining Class A revolver maturity to 2029, allows part PIK interest (Adj. SOFR + 8 %) and waives term-loan amortization until 31 Dec 2026. Leverage and asset coverage covenants removed.
- Equity issuance: Lenders received 4,766,219 Class A shares (~19.99 % of pre-transaction shares) in a private placement.
- Board changes: Three directors appointed (Timothy R. Pohl, Alan J. Carr, William L. Transier); three directors resigned. A new Transformation Committee will evaluate strategic alternatives.
The package provides fresh capital and maturity relief but at high cost and with substantial dilution and restrictive covenants.
GoHealth (Nasdaq: GOCO) filed an 8-K disclosing the results of its 2025 Annual Meeting of Stockholders held on June 18, 2025.
Shareholders elected three Class II directors鈥擝randon M. Cruz (17,218,021 FOR), Alan Wheatley (17,932,740 FOR) and Abhiraj R. Modi (17,619,537 FOR)鈥攖o serve until the 2028 meeting. Ernst & Young LLP was ratified as independent auditor with 21,544,738 FOR and only 557,922 AGAINST. The non-binding say-on-pay resolution passed (17,026,293 FOR; 992,227 AGAINST), and shareholders approved an amendment to the 2020 Incentive Award Plan (16,755,619 FOR; 1,287,341 AGAINST).
No financial performance metrics, strategic updates, or other material events were included in the filing.
FAQ
What is the current stock price of Gohealth (GOCO)?
What is the market cap of Gohealth (GOCO)?
